To all our CKB CORE users, don’t miss the latest new features now available! Register for a free CORE account here and then login for access. Feel free to contact us at ckbsupport@genomenon.com if you have any questions!

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT04931654
Title A Study to Assess the Safety and Efficacy of AZD7789 in Participants With Advanced or Metastatic Solid Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors AstraZeneca
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | TUR | NLD | FRA | ESP | CAN

Facility Status City State Zip Country Details
Research Site Atlanta Georgia 30322 United States Details
Research Site Fort Wayne Indiana 46804 United States Details
Research Site New York New York 10029 United States Details
Research Site Nashville Tennessee 37203 United States Details
Research Site Toronto Ontario M5G 2M9 Canada Details
Research Site Beijing 100142 China Details
Research Site Guangzhou 510060 China Details
Research Site Bordeaux 33076 France Details
Research Site Rennes 35000 France Details
Research Site Villejuif Cedex 94805 France Details
Research Site Tbilisi 0112 Georgia Details
Research Site Chuo-ku 104-0045 Japan Details
Research Site Kashiwa 277-8577 Japan Details
Research Site Sendai-shi 981-0914 Japan Details
Research Site Chisinau MD-2025 Moldova, Republic of Details
Research Site Amsterdam 1066 CX Netherlands Details
Research Site Barcelona 08035 Spain Details
Research Site Madrid 28027 Spain Details
Research Site Ankara 06010 Turkey Details
Research Site Ankara 06200 Turkey Details
Research Site Ankara 06800 Turkey Details
Research Site Istanbul 34722 Turkey Details
Research Site Karsiyaka 35575 Turkey Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field